Showing 1,061 - 1,080 results of 10,612 for search '"real life"', query time: 0.23s Refine Results
  1. 1061
  2. 1062
  3. 1063

    Prognostic factors, effectiveness and safety of endoscopic balloon dilatation for de novo and anastomotic strictures in Crohn’s disease—A multicenter “real life” study by Anita Bálint, Dalma Törőcsik, Károly Palatka, Zoltán Szepes, Mónika Szűcs, Ferenci Tamás, Ferenc Nagy, Klaudia Farkas, Anna Fábián, Renáta Bor, Ágnes Milassin, Mariann Rutka, Tamás Molnár

    Published 2016-12-01
    “…Introduction: Crohn’s disease (CD) is a chronic inflammatory disease which is frequently complicated by obstructive symptoms secondary to development of intestinal strictures. The aim of this “real life” study was to assess the effectiveness, safety and outcome of endoscopic balloon dilatation (EBD) in de novo vs. anastomotic stenoses. …”
    Get full text
    Article
  4. 1064
  5. 1065
  6. 1066
  7. 1067
  8. 1068

    Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine by Paola Sarchielli, Michele Romoli, Ilenia Corbelli, Laura Bernetti, Angela Verzina, Elona Brahimi, Paolo Eusebi, Stefano Caproni, Paolo Calabresi, Paolo Calabresi

    Published 2017-12-01
    “…This prospective study aimed to define, in real-life setting, the evolution of the response to OnabotA over five cycles of treatment among patients non-responding to cycle 1. …”
    Get full text
    Article
  9. 1069
  10. 1070

    Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study by Giammarco Mocci, Giorgia Bodini, Leonardo Allegretta, Alessia Immacolata Cazzato, Stefania Chiri, Giovanni Aragona, Patrizia Perazzo, Antonio Ferronato, Maria Giovanna Graziani, Cristiano Pagnini, Costantino Zampaletta, Camilla Graziosi, Marcello Picchio, Walter Elisei, Giovanni Maconi, Antonio Tursi

    Published 2022-07-01
    “…We compared the efficacy and safety of GP2017 versus originator in IBD outpatients in an Italian real-life setting. This retrospective analysis enrolled consecutive IBD patients with complete clinical, laboratory, and endoscopic data. …”
    Get full text
    Article
  11. 1071

    Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings by Fang Cheng, Fang Cheng, Fang Cheng, Qiang Li, Qiang Li, Zheng Cui, Zheng Cui, Mei Hong, Weiming Li, Yu Zhang, Yu Zhang

    Published 2023-04-01
    “…This review focuses mainly on the latest research of dose optimization of imatinib, dasatinib, and nilotinib in CML clinical trials and real-life settings. We consider dose reduction in newly diagnosed patients, or in optimal response, or for improving AEs, either as a prelude to treatment-free remission (TFR) or as maintenance therapy in those patients unable to discontinue TKIs therapy. …”
    Get full text
    Article
  12. 1072
  13. 1073
  14. 1074
  15. 1075
  16. 1076
  17. 1077
  18. 1078
  19. 1079
  20. 1080

    Last Resort Antibiotics Costs and Reimbursement Analysis of Real-Life ICU Patients with Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacteria in Germany by Julia Jeck, Sebastian M. Wingen-Heimann, Florian Jakobs, Jennifer Franz, Christoph T. Baltin, Anna Kron, Boris Böll, Matthias Kochanek, Oliver A. Cornely, Florian Kron

    Published 2022-12-01
    “…Retrospective analyses based on medical charts and real-life reimbursement data included patients with pneumonia due to MDR-GNB treated in intensive care units (ICU) of a German tertiary care hospital (University Hospital Cologne) between January 2017 and December 2020. …”
    Get full text
    Article